Michael Raab

Companies

• Tempest Therapeutics, Inc.Board member Jun 29, 2021 to now¹
• Ardelyx (United States)Board member Jun 18, 2014 to now²
• Ardelyx (United States)Chief executive officer Jun 18, 2014 to now²
• Ardelyx (United States)President Jun 18, 2014 to now²
• Amicus TherapeuticsBoard member May 30, 2007 to now³
• Paratek Pharmaceuticals, Inc.Board member May 9, 2006 to Feb 2, 2009⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• AUArdelyx (United States) ARDX1,620,792 shares⁵$5.0M at $3.10Aug 25, 2026
• Amicus Therapeutics FOLD0 shares⁶Apr 27, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 21, 2026Sold 19,178 shares at $3.86 of Ardelyx (United States)⁵
• Aug 21, 2026Sold 8,411 shares at $3.86 of Ardelyx (United States)⁵
• Aug 21, 2026Sold 15,976 shares at $3.86 of Ardelyx (United States)⁵
• Aug 21, 2026Sold 15,009 shares at $3.86 of Ardelyx (United States)⁵
• Jul 15, 2026Sold 41,668 shares at $5.06 of Ardelyx (United States)⁷
• Jul 15, 2026Exercised options 20,834 shares at $0.99 of Ardelyx (United States)⁷
• Jun 15, 2026Sold 41,666 shares at $5.67 of Ardelyx (United States)⁸
• Jun 15, 2026Exercised options 20,833 shares at $0.99 of Ardelyx (United States)⁸
• May 21, 2026Sold 14,028 shares at $6.27 of Ardelyx (United States)⁹
• May 21, 2026Sold 17,926 shares at $6.27 of Ardelyx (United States)⁹
• May 21, 2026Sold 7,861 shares at $6.27 of Ardelyx (United States)⁹
• May 21, 2026Sold 14,933 shares at $6.27 of Ardelyx (United States)⁹
• May 15, 2026Sold 41,666 shares at $6.28 of Ardelyx (United States)¹⁰
• May 15, 2026Exercised options 20,833 shares at $0.99 of Ardelyx (United States)¹⁰
• Apr 27, 2026Returned to company 115,857 shares at $14.50 of Amicus Therapeutics⁶
• Apr 15, 2026Sold 41,668 shares at $6.29 of Ardelyx (United States)¹¹
• Apr 15, 2026Exercised options 20,834 shares at $0.99 of Ardelyx (United States)¹¹
• Mar 16, 2026Sold 41,666 shares at $5.84 of Ardelyx (United States)¹²
• Mar 16, 2026Exercised options 20,833 shares at $0.99 of Ardelyx (United States)¹²
• Feb 24, 2026Sold 41,666 shares at $6.26 of Ardelyx (United States)¹³
• Feb 24, 2026Exercised options 20,833 shares at $0.99 of Ardelyx (United States)¹³
• Feb 20, 2026Sold 2 shares at $5.70 of Ardelyx (United States)¹⁴
• Feb 20, 2026Sold 1 shares at $5.70 of Ardelyx (United States)¹⁴
• Feb 20, 2026Sold 2 shares at $5.70 of Ardelyx (United States)¹⁴
• Feb 20, 2026Sold 5,576 shares at $5.71 of Ardelyx (United States)¹⁴